Health Care [ 5/12 ] | Health Care Equipment & Supplies [ 26/74 ]
NASDAQ | Common Stock
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally.
It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.
The company also develops NADI " Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya is an enabling digital platform that compliments the SSI Mantra system and enhances surgical capabilities; SSi Guru is a virtual tele illustration; SSi XR Cognitive Skill Simulator is an extended reality (XR) software platform developed to train and educate surgeons and surgical assistants; SSi MantraM; SSi Mantra Tele Surgeon Console (TSC); and 5mm surgical instruments; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa " Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device.
In addition, it offers instrument tips, including forceps, scissors, electrocautery tools, scalpels, and other surgical tools.
Further, the company provides accessory products, such as sterile drapes, 3d stereo endoscopes, cannulas, and seals, as well as tele proctoring and telesurgery products.
Additionally, it offers installation, repair, maintenance, 24/7 technical support, and proactive health monitoring services.
The company sells its products through direct sales organizations and distributor networks.
SS Innovations International, Inc. is headquartered in Gurugram, India.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 14, 26 | -0.02 Increased by +42.45% | - |
| Mar 10, 26 | -0.01 Decreased by -13.39% | - |
| Oct 28, 25 | -0.02 Increased by +44.13% | - |
| Aug 6, 25 | -0.00 Increased by +92.44% | - |
| May 13, 25 | -0.03 Decreased by -93.90% | - |
| Mar 20, 25 | -0.01 Increased by +88.14% | - |
| Nov 11, 24 | -0.04 Decreased by -177.52% | - |
| Aug 12, 24 | -0.02 Increased by +55.32% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 11.08 M Increased by +116.46% | -3.58 M Increased by +36.94% | Decreased by -32.32% Increased by +70.87% |
| Dec 31, 25 | 14.53 M Increased by +158.45% | -2.47 M Increased by +66.84% | Decreased by -17.00% Increased by +87.17% |
| Sep 30, 25 | 12.83 M Increased by +192.47% | -3.72 M Decreased by -14.56% | Decreased by -28.98% Increased by +60.83% |
| Jun 30, 25 | 10.00 M Increased by +128.00% | -256.69 K Increased by +91.24% | Decreased by -2.57% Increased by +96.16% |
| Mar 31, 25 | 5.12 M Decreased by -25.26% | -5.68 M Decreased by -103.02% | Decreased by -110.95% Decreased by -171.63% |
| Dec 31, 24 | 5.62 M Increased by +312.53% | -7.45 M Increased by +53.77% | Decreased by -132.51% Increased by +88.79% |
| Sep 30, 24 | 4.39 M Increased by +206.80% | -3.25 M Decreased by -63.59% | Decreased by -73.99% Increased by +46.68% |
| Jun 30, 24 | 4.39 M Increased by +178.43% | -2.93 M Decreased by -58.44% | Decreased by -66.84% Increased by +43.09% |